The cystatin C-derived eGFR (CAPA) was lower than the creatinine-derived eGFR (CKD-EPI) in ≈84% of no-CKD and ≈82% of at-risk (TAVI) cases. The gene discussed is CST3; the disease is chronic kidney disease.